Among high-risk patients who received a placebo, 10% were hospitalized, compared to just 2% of those who received the drug cocktail – a 70% drop.
Author: Karen Weintraub, USA TODAY
Nursing home residents, caregivers who want COVID-19 vaccine should have had first shot by Monday, pharmacies say
Every nursing home resident and caregiver in America who wants to be vaccinated against COVID-19 should have gotten their first shot by Monday.
Biden administration renewed support for World Health Organization is ‘good news for America and the world,’ scientists say
Health experts say reversing Trump administration withdrawal from the international body is good news for the WHO, America and the world.
Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports
A study of nursing home residents found the monoclonal antibody treatment bamlanivimab cut the risk of COVID-19 by up to 80%, maker Eli Lilly announced.
Moderna struggles to find 3,000 adolescent volunteers needed for COVID-19 vaccine trial
More than 2 million minors were diagnosed with COVID-19 in 2020, and many more probably contracted the disease but were never diagnosed.
Should you be more worried about new coronavirus variants? Not yet, experts say.
The two authorized COVID-19 vaccines and others under development are expected to continue to be effective against the new strains of the coronavirus.
COVID-19 vaccine doses have been delivered but are sitting on pharmacy shelves. Longer delays could prolong the pandemic
If the pace of COVID-19 vaccination doesn’t pick up soon, the pandemic will continue to dominate life in America longer than officials have predicted.
For pregnant and nursing women, risks of COVID-19 probably outweigh risk of vaccine, experts say
Experts say the choice to get a COVID-19 vaccine should rest with the woman, but the benefits likely outweigh the risk in those pregnant or nursing.
US gets more help in raging battle against COVID-19 as FDA authorizes Moderna vaccine, the second allowed for emergency use
Moderna’s COVID vaccine, the second cleared for use in the U.S., will be shipped this weekend, with first doses expected to be given Monday.
Moderna’s COVID-19 vaccine gets panel support, set to become the second cleared by FDA for use in US
An expert panel recommended Thursday that the FDA authorize Moderna’s COVID-19 vaccine. Doses could reach states by next week.